This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Nutritional and Metabolic Disorders, Other  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

The CDC Diabetes Cost-effectiveness Group

JAMA. 2002;287:2542-2551.

Context  Several treatment interventions can reduce complications of type 2 diabetes, but their relative cost-effectiveness is not known.

Objective  To estimate the incremental cost-effectiveness of intensive glycemic control (relative to conventional control), intensified hypertension control, and reduction in serum cholesterol level for patients with type 2 diabetes.

Design, Setting, and Patients  Cost-effectiveness analysis of a hypothetical cohort of individuals living in the United States, aged 25 years or older, who were newly diagnosed as having type 2 diabetes. The results of the United Kingdom Prospective Diabetes Study (UKPDS) and other studies were used to create a model of disease progression and treatment patterns. Costs were based on those used in community practices in the United States.

Interventions  Insulin or sulfonylurea therapy for intensive glycemic control; angiotensin-converting enzyme inhibitor or -blocker for intensified hypertension control; and pravastatin for reduction of serum cholesterol level.

Main Outcome Measures  Cost per quality-adjusted life-year (QALY) gained. Costs (in 1997 US dollars) and QALYs were discounted at a 3% annual rate.

Results  The incremental cost-effectiveness ratio for intensive glycemic control is $41 384 per QALY; this ratio increased with age at diagnosis from $9614 per QALY for patients aged 25 to 34 years to $2.1 million for patients aged 85 to 94 years. For intensified hypertension control the cost-effectiveness ratio is -$1959 per QALY. The cost-effectiveness ratio for reduction in serum cholesterol level is $51 889 per QALY; this ratio varied by age at diagnosis and is lowest for patients diagnosed between the ages of 45 and 84 years.

Conclusions  Intensified hypertension control reduces costs and improves health outcomes relative to moderate hypertension control. Intensive glycemic control and reduction in serum cholesterol level increase costs and improve health outcomes. The cost-effectiveness ratios for these 2 interventions are comparable with those of several other frequently adopted health care interventions.

Affiliations of the Members of the CDC Diabetes Cost-effectiveness Group: Thomas J. Hoerger, PhD, Albert D. Bethke, PhD, and Anke Richter, PhD, Research Triangle Institute, Research Triangle Park, NC; Stephen W. Sorensen, PhD, Michael Engelgau, MD, Ted Thompson, MS, K. M. Venkat Narayan, MD, David F. Williamson, PhD, Edward Gregg, PhD, and Ping Zhang, PhD, Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Ga; Richard C. Eastman, MD, Cygnus Inc; John Fuller, MD, University College, London, England; Claire B. Gibbons, MPH, University of North Carolina School of Public Health, Chapel Hill; Steve Haffner, MD, University of Texas Health Center, San Antonio ; William H. Herman, MD, University of Michigan Medical Center, Ann Arbor; Barbara Howard, PhD, and Robert Ratner, MD, MedStar Research Institute, Washington, DC; and Trevor Orchard, MB BCh, University of Pittsburgh, Pittsburgh, Pa.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

May 15, 2002
JAMA. 2002;287(19):2593-2994.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Effect of Medicare Part D on Drug and Medical Spending
Zhang et al.
NEJM 2009;361:52-61.
ABSTRACT | FULL TEXT  

A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus: 5 Year Results of the IDEATel Study
Shea et al.
J. Am. Med. Inform. Assoc. 2009;16:446-456.
ABSTRACT | FULL TEXT  

Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Pletcher et al.
ANN INTERN MED 2009;150:243-254.
ABSTRACT | FULL TEXT  

Update on the Canadian Diabetes Association 2008 clinical practice guidelines
Bhattacharyya et al.
cfp 2009;55:39-43.
FULL TEXT  

Costs and Benefits Associated With Diabetes Education: A Review of the Literature
Boren et al.
The Diabetes Educator 2009;35:72-96.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Automated Telephone Self-Management Support With Nurse Care Management Among Patients With Diabetes
Handley et al.
Ann Fam Med 2008;6:512-518.
ABSTRACT | FULL TEXT  

Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines
Bhattacharyya et al.
CMAJ 2008;179:920-926.
FULL TEXT  

Depression in Patients with Diabetes: Does It Impact Clinical Goals?
Rush et al.
J Am Board Fam Med 2008;21:392-397.
ABSTRACT | FULL TEXT  

Approaches to Treatment of Type 2 Diabetes
Bloomgarden
Diabetes Care 2008;31:1697-1703.
FULL TEXT  

Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes: Results and projections from the Steno-2 study
Gaede et al.
Diabetes Care 2008;31:1510-1515.
ABSTRACT | FULL TEXT  

The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis
Huang et al.
ANN INTERN MED 2008;149:11-19.
ABSTRACT | FULL TEXT  

Hypertension management in Canada: good news, but important challenges remain
Mohan and Campbell
CMAJ 2008;178:1458-1460.
FULL TEXT  

It's Time to Overcome Clinical Inertia
Phillips and Twombly
ANN INTERN MED 2008;148:783-785.
FULL TEXT  

Choosing an Insulin Regimen for Patients With Type 2 Diabetes
Pignone
Clin. Diabetes 2008;26:63-64.
FULL TEXT  

Actively Engaging Patients in Treatment Decision Making and Monitoring as a Strategy to Improve Hypertension Outcomes in Diabetes Mellitus
Heisler
Circulation 2008;117:1355-1357.
FULL TEXT  

Sex Disparities in Control and Treatment of Modifiable Cardiovascular Disease Risk Factors Among Patients With Diabetes: Translating Research Into Action for Diabetes (TRIAD) Study
Ferrara et al.
Diabetes Care 2008;31:69-74.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults
Hoerger et al.
Diabetes Care 2007;30:2874-2879.
ABSTRACT | FULL TEXT  

Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments
Huang et al.
Diabetes Care 2007;30:2478-2483.
ABSTRACT | FULL TEXT  

"Doctor, How Certain Are We That This Diabetes Medication Is Best for Me?"
Pogach
ANN INTERN MED 2007;147:428-430.
FULL TEXT  

Computer Modeling of Diabetes and Its Complications: A report on the Fourth Mount Hood Challenge Meeting
The Mount Hood 4 Modeling Group
Diabetes Care 2007;30:1638-1646.
ABSTRACT | FULL TEXT  

Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): Good for Sulfonylureas?
Al-Ozairi et al.
Diabetes Care 2007;30:1677-1680.
FULL TEXT  

Intensive Glucose Control in Elderly Adults
Hayward et al.
JAMA 2007;297:2195-2195.
FULL TEXT  

Glycemic Control and Absenteeism Among Individuals With Diabetes
Tunceli et al.
Diabetes Care 2007;30:1283-1285.
FULL TEXT  

Cost-Effectiveness of Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease
Oba
Mayo Clin Proc. 2007;82:575-582.
ABSTRACT | FULL TEXT  

Measuring Progress Toward Achieving Hemoglobin A1c Goals in Diabetes Care: Pass/Fail or Partial Credit
Pogach et al.
JAMA 2007;297:520-523.
FULL TEXT  

Summary measures of quality of diabetes care: comparison of continuous weighted performance measurement and dichotomous thresholds
Aron et al.
Int J Qual Health Care 2007;19:29-36.
ABSTRACT | FULL TEXT  

Anemia in cancer and critical care patients: Pharmacoeconomic considerations
Reeder
Am J Health Syst Pharm 2007;64:S22-S27.
ABSTRACT | FULL TEXT  

Is the Number of Documented Diabetes Process-of-Care Indicators Associated With Cardiometabolic Risk Factor Levels, Patient Satisfaction, or Self-Rated Quality of Diabetes Care?: The Translating Research into Action for Diabetes (TRIAD) study.
Ackermann et al.
Diabetes Care 2006;29:2108-2113.
ABSTRACT | FULL TEXT  

An Evaluation of Cost Sharing to Finance a Diet and Physical Activity Intervention to Prevent Diabetes.
Ackermann et al.
Diabetes Care 2006;29:1237-1241.
ABSTRACT | FULL TEXT  

Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988-2002
Saaddine et al.
ANN INTERN MED 2006;144:465-474.
ABSTRACT | FULL TEXT  

Antihypertensive Medication Prescribing in 27,822 Elderly Canadians With Diabetes Over the Past Decade
McAlister et al.
Diabetes Care 2006;29:836-841.
ABSTRACT | FULL TEXT  

Economic Evaluation of Angiotensin Receptor Blockers in Type 2 Diabetes, Hypertension, and Nephropathy
Ravera et al.
J. Am. Soc. Nephrol. 2006;17:S44-S48.
ABSTRACT | FULL TEXT  

Comparison of Weighted Performance Measurement and Dichotomous Thresholds for Glycemic Control in the Veterans Health Administration
Pogach et al.
Diabetes Care 2006;29:241-246.
ABSTRACT | FULL TEXT  

The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes
Huang et al.
Diabetes Care 2006;29:259-264.
ABSTRACT | FULL TEXT  

Management of Hypertension in Diabetes
Stults and Jones
Diabetes Spectr. 2006;19:25-31.
ABSTRACT | FULL TEXT  

A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus
Shea et al.
J. Am. Med. Inform. Assoc. 2006;13:40-51.
ABSTRACT | FULL TEXT  

A Computer Simulation Model of Diabetes Progression, Quality of Life, and Cost
Zhou et al.
Diabetes Care 2005;28:2856-2863.
ABSTRACT | FULL TEXT  

Quality of Care of Medicare Patients With Diabetes in a Metropolitan Fee-for-Service Primary Care Integrated Delivery System
Hollander et al.
American Journal of Medical Quality 2005;20:344-352.
ABSTRACT  

Association Among Individual Deprivation, Glycemic Control, and Diabetes Complications: The EPICES score
Bihan et al.
Diabetes Care 2005;28:2680-2685.
ABSTRACT | FULL TEXT  

Diabetes Outcomes in the Indian Health System During the Era of the Special Diabetes Program for Indians and the Government Performance and Results Act
Wilson et al.
Am. J. Public Health 2005;95:1518-1522.
ABSTRACT | FULL TEXT  

How Much Time Do Patients with Diabetes Spend on Self-Care?
Safford et al.
J Am Board Fam Med 2005;18:262-270.
ABSTRACT | FULL TEXT  

The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance
Herman et al.
ANN INTERN MED 2005;142:323-332.
ABSTRACT | FULL TEXT  

Economic evaluation of sirolimus-eluting stents
Shrive et al.
CMAJ 2005;172:345-351.
ABSTRACT | FULL TEXT  

Specialist Nurse-Led Clinics to Improve Control of Hypertension and Hyperlipidemia in Diabetes: Economic analysis of the SPLINT trial
Mason et al.
Diabetes Care 2005;28:40-46.
ABSTRACT | FULL TEXT  

Predictors of Health Care Costs in Adults With Diabetes
Gilmer et al.
Diabetes Care 2005;28:59-64.
ABSTRACT | FULL TEXT  

Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes
Pladevall et al.
Diabetes Care 2004;27:2800-2805.
ABSTRACT | FULL TEXT  

Intensive Integrated Therapy of Type 2 Diabetes: Implications for Long-Term Prognosis
Gaede and Pedersen
Diabetes 2004;53:S39-S47.
ABSTRACT | FULL TEXT  

Can Disease Management Reduce Health Care Costs By Improving Quality?
Fireman et al.
Health Aff (Millwood) 2004;23:63-75.
ABSTRACT | FULL TEXT  

Recent advances in diabetic nephropathy
Marshall
Postgrad. Med. J. 2004;80:624-633.
ABSTRACT | FULL TEXT  

Guidelines for Computer Modeling of Diabetes and Its Complications
American Diabetes Association Consensus Panel
Diabetes Care 2004;27:2262-2265.
FULL TEXT  

Diabetes Care Quality in the Veterans Affairs Health Care System and Commercial Managed Care: The TRIAD Study
Kerr et al.
ANN INTERN MED 2004;141:272-281.
ABSTRACT | FULL TEXT  

Improvements in Patient-Reported Outcomes Associated With an Intervention to Enhance Quality of Care for Rural Patients With Type 2 Diabetes: Results of a controlled trial
Maddigan et al.
Diabetes Care 2004;27:1306-1312.
ABSTRACT | FULL TEXT  

Application of Economic Analysis to Diabetes and Diabetes Care
Zhang et al.
ANN INTERN MED 2004;140:972-977.
ABSTRACT | FULL TEXT  

Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis
Hoerger et al.
ANN INTERN MED 2004;140:689-699.
ABSTRACT | FULL TEXT  

Are Low-Income Elderly Patients at Risk for Poor Diabetes Care?
McCall et al.
Diabetes Care 2004;27:1060-1065.
ABSTRACT | FULL TEXT  

Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of Physicians
Vijan and Hayward
ANN INTERN MED 2004;140:650-658.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Prevention and Treatment of the Diabetic Foot: A Markov analysis
Ortegon et al.
Diabetes Care 2004;27:901-907.
ABSTRACT | FULL TEXT  

Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes
Saydah et al.
JAMA 2004;291:335-342.
ABSTRACT | FULL TEXT  

Diabetic Patients Who Smoke: Are They Different?
Solberg et al.
Ann Fam Med 2004;2:26-32.
ABSTRACT | FULL TEXT  

Closing the Gap: Effect of Diabetes Case Management on Glycemic Control Among Low-Income Ethnic Minority Populations: The California Medi-Cal Type 2 Diabetes Study
The California Medi-Cal Type 2 Diabetes Study Grou
Diabetes Care 2004;27:95-103.
ABSTRACT | FULL TEXT  

Overcome Clinical Inertia to Control Systolic Blood Pressure
O'Connor
Arch Intern Med 2003;163:2677-2678.
FULL TEXT  

Controlled Trial of a Multifaceted Intervention for Improving Quality of Care for Rural Patients With Type 2 Diabetes
Majumdar et al.
Diabetes Care 2003;26:3061-3066.
ABSTRACT | FULL TEXT  

Archimedes: A trial-validated model of diabetes
Eddy and Schlessinger
Diabetes Care 2003;26:3093-3101.
ABSTRACT | FULL TEXT  

Dealing With Complexity in Clinical Diabetes: The value of Archimedes
Kahn
Diabetes Care 2003;26:3168-3171.
FULL TEXT  

Diabetes Modeling
Herman
Diabetes Care 2003;26:3182-3183.
FULL TEXT  

Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy
Rothberg et al.
ANN INTERN MED 2003;139:321-329.
ABSTRACT | FULL TEXT  

Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes
Diabetes Prevention Program Research Group
Diabetes Care 2003;26:2518-2523.
ABSTRACT | FULL TEXT  

Considerations for Diabetes Translational Research in Real-World Settings
Garfield et al.
Diabetes Care 2003;26:2670-2674.
FULL TEXT  

Setting evidence-based priorities for diabetes care improvement
O'Connor
Int J Qual Health Care 2003;15:283-285.
FULL TEXT  

The Direct Medical Cost of Type 2 Diabetes
Brandle et al.
Diabetes Care 2003;26:2300-2304.
ABSTRACT | FULL TEXT  

The Diabetes Prevention Program and Its Global Implications
Molitch et al.
J. Am. Soc. Nephrol. 2003;14:S103-107.
ABSTRACT | FULL TEXT  

Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care
Vijan and Hayward
ANN INTERN MED 2003;138:593-602.
ABSTRACT | FULL TEXT  

Treating Type 2 Diabetes Mellitus: A Growing Epidemic
Weinstock
Mayo Clin Proc. 2003;78:411-413.
 

Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes
Merz et al.
J Am Coll Cardiol 2002;40:1877-1881.
ABSTRACT | FULL TEXT  

Optimal Allocation of Resources Across Four Interventions for Type 2 Diabetes
Earnshaw et al.
Med Decis Making 2002;22:S80-S91.
ABSTRACT  

JournalScan
Malik
Heart 2002;88:207-208.
FULL TEXT  

Progress and Promise of Diabetes Research
Saudek
JAMA 2002;287:2582-2584.
FULL TEXT